| Literature DB >> 31156518 |
Marco Lauriola1, Manuela Tomai2, Rossella Palma3, Gaia La Spina2, Anastasia Foglia2, Cristina Panetta3, Marilena Raniolo3, Stefano Pontone3.
Abstract
Although sedatives can defuse anxiety and relieve pain, Esophagogastroduodenoscopy (EGD) still is uncomfortable and threatening for some patients. Identifying patients who tolerate digestive endoscopy less well remains difficult. Using a prospective design and a multimodal assessment of pain, the present study evaluated how anxiety-related variables predicted subsequent pain outcomes. Sixty-two consecutive patients referred for elective EGD were assessed for intolerance of uncertainty (IU), procedure-related worries, anxiety sensitivity and health distress before endoscopy. During endoscopy, a doctor rated patients' pain behavior. After complete recovery from sedation, the patients retrospectively rated endoscopy pain and situation specific catastrophizing thoughts. Descriptive analyses showed that patients undergoing EGD for the first time were more distressed and anxious than patients accustomed to the procedure and needed a higher sedative dose. Notwithstanding sedation, the behavioral rating of pain was above the cut-off value for probable pain for more than half of the patients. IU assessed before endoscopy predicted situational pain catastrophizing (PC) and self-reported pain after endoscopy through procedure related worries. Situational PC not only mediated the effect of worry, but also female gender and younger age were associated with self-reported pain through increased catastrophizing thoughts. Health distress and anxiety sensitivity predicted PC only for women, younger patients, and those not accustomed to the procedure. Our study showed that psychological preparation before sedation is needed especially for first-timers, women, and younger patients, addressing maladaptive cognitive beliefs and acquainting patients with the somatic sensations that they might experience during the procedure.Entities:
Keywords: anxiety-sensitivity; esophagogastroduodenoscopy; intolerance of uncertainty; pain catastrophizing; procedural anxiety; prospective-study
Year: 2019 PMID: 31156518 PMCID: PMC6529782 DOI: 10.3389/fpsyg.2019.01112
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
FIGURE 1Theoretical model and hypotheses.
Sedation and pain variables in the total sample and broken by gender and previous EGD experience.
| Total sample | Men | Women | First-timers | Experienced | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variables (range) | ||||||||||||||
| Ramsey sedation score (1–5) | 2.84 | (0.75) | 2.77 | (0.76) | 2.90 | (0.75) | 0.67 | 2.93 | (0.68) | 2.77 | (0.81) | 0.80 | ||
| Midazolam (mg/l) | 2.97 | (1.16) | 2.84 | (1.13) | 3.10 | (1.19) | 0.88 | 3.41 | (0.97) | 2.63 | (1.19) | 2.76 | ∗∗ | |
| BMI (Kg/m2) | 24.28 | (3.90) | 24.61 | (3.37) | 23.95 | (4.40) | 0.67 | 24.67 | (3.90) | 23.98 | (3.93) | 0.69 | ||
| PAINAD total (0–13) | 1.68 | (2.06) | 1.48 | (2.26) | 1.87 | (1.86) | 0.74 | 1.89 | (2.03) | 1.51 | (2.11) | 0.71 | ||
| Breathing (0–2) | 0.13 | (0.34) | 0.12 | (0.34) | 0.13 | (0.33) | 0.00 | 0.15 | (0.36) | 0.11 | (0.32) | 0.39 | ||
| Negative vocalizations (0–2) | 0.34 | (0.51) | 0.32 | (0.54) | 0.35 | (0.49) | 0.25 | 0.41 | (0.50) | 0.29 | (0.52) | 0.93 | ||
| Facial expression (0–2) | 0.44 | (0.53) | 0.35 | (0.55) | 0.52 | (0.51) | 1.20 | 0.37 | (0.49) | 0.49 | (0.56) | 0.84 | ||
| Body language (0–2) | 0.44 | (0.53) | 0.39 | (0.56) | 0.48 | (0.51) | 0.71 | 0.52 | (0.51) | 0.37 | (0.55) | 1.08 | ||
| Consolability (0–2) | 0.34 | (0.51) | 0.29 | (0.53) | 0.39 | (0.50) | 0.74 | 0.44 | (0.51) | 0.26 | (0.51) | 1.45 | ||
| Self-report pain total (z-score) | 0.00 | (1.00) | –0.31 | (0.91) | 0.31 | (1.00) | 2.59 | ∗ | 0.14 | (0.95) | –0.11 | (1.04) | 0.98 | |
| Verbal scale (0–5) | 4.09 | (3.99) | 2.91 | (3.03) | 5.26 | (4.52) | 2.41 | ∗ | 4.30 | (4.40) | 3.92 | (3.71) | 0.37 | |
| Visual analog scale (0–100) | 1.61 | (1.38) | 1.26 | (1.29) | 1.97 | (1.40) | 2.07 | ∗ | 1.85 | (1.32) | 1.43 | (1.42) | 1.20 | |
| Face scale (0–5) | 2.21 | (1.16) | 1.81 | (0.95) | 2.61 | (1.23) | 2.89 | ∗∗ | 2.59 | (1.15) | 1.91 | (1.09) | 2.36 | ∗ |
| Numeric scale (0–10) | 2.48 | (2.60) | 2.03 | (2.66) | 2.94 | (2.49) | 1.38 | 2.33 | (2.29) | 2.60 | (2.84) | 0.40 | ||
| Pain catastrophizing (0–36) | 8.20 | (9.03) | 4.93 | (6.33) | 11.35 | (10.17) | 2.95 | ∗∗ | 10.67 | (9.60) | 6.24 | (8.17) | 1.95 | † |
| Pain helplessness (0–13) | 0.48 | (0.66) | 0.22 | (0.48) | 0.73 | (0.72) | 3.22 | ∗∗ | 0.63 | (0.71) | 0.35 | (0.61) | 1.64 | |
| Pain rumination (0–17) | 0.87 | (0.93) | 0.51 | (0.66) | 1.21 | (1.03) | 3.11 | ∗∗ | 1.13 | (1.00) | 0.66 | (0.83) | 1.99 | † |
| Pain magnification (0–8) | 0.51 | (0.82) | 0.53 | (0.69) | 0.48 | (0.94) | 0.23 | 0.63 | (0.98) | 0.41 | (0.67) | 1.03 | ||
Psychological variables in the total sample and broken by gender and first-time EGD.
| Total sample | Men | Women | First-timers | Experienced | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variables (range) | ||||||||||||||
| IU total (10–50) | 23.25 | (9.64) | 22.86 | (10.1) | 23.63 | (9.36) | 0.30 | 24.96 | (7.91) | 21.81 | (10.80) | 1.26 | ||
| AS total (0–48) | 11.93 | (9.90) | 9.24 | (6.76) | 14.53 | (11.7) | 2.11 | ∗ | 13.44 | (9.07) | 10.66 | (10.51) | 1.08 | |
| AS cognitive (0–24) | 5.44 | (5.29) | 3.97 | (3.66) | 6.87 | (6.18) | 2.17 | ∗ | 5.77 | (4.62) | 5.16 | (5.86) | 0.45 | |
| AS sens. physical (0–24) | 6.01 | (6.49) | 5.28 | (4.21) | 7.67 | (6.01) | 1.76 | † | 7.67 | (5.23) | 5.50 | (5.23) | 1.58 | |
| Health distress (1–28) | 11.86 | (5.56) | 10.90 | (5.83) | 12.83 | (5.19) | 1.33 | 13.33 | (5.43) | 10.58 | (5.43) | 1.93 | † | |
| Anxiety (0–14) | 6.95 | (3.49) | 6.34 | (3.34) | 7.55 | (3.59) | 1.33 | 7.89 | (3.40) | 6.13 | (3.14) | 1.96 | † | |
| Depression (0–14) | 4.91 | (3.23) | 4.55 | (3.55) | 5.28 | (2.90) | 0.85 | 6.13 | (3.41) | 4.45 | (3.29) | 1.17 | ||
| Worry total (1–5) | 2.42 | (1.03) | 2.24 | (0.95) | 2.60 | (1.09) | 1.38 | 2.70 | (1.04) | 2.19 | (0.97) | 1.97 | † | |
| Worry EGD procedure (1–5) | 2.36 | (1.16) | 2.07 | (1.02) | 2.63 | (1.24) | 1.91 | † | 2.66 | (1.22) | 2.10 | (1.06) | 1.87 | † |
| Worry EGD outcomes (1–5) | 2.55 | (1.20) | 2.34 | (1.07) | 2.75 | (1.30) | 1.30 | 2.83 | (1.16) | 2.31 | (1.20) | 1.68 | † | |
| Worry general health (1–5) | 2.43 | (1.26) | 2.47 | (1.35) | 2.40 | (1.18) | 0.20 | 2.67 | (1.33) | 2.23 | (1.18) | 1.32 | ||
Reliability and validity of the latent variables.
| AVE | CR | 1. | 2. | 3. | 4. | 5. | 6. | 7. | 8. | 9. | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Intolerance of uncertainty | 0.94 | 0.97 | 0.97*** | |||||||||
| 2. Anxiety sensitivity | 0.87 | 0.93 | 0.70*** | 0.93*** | ||||||||
| 3. Health distress | 0.67 | 0.80 | 0.63*** | 0.60*** | 0.82*** | |||||||
| 4. Worry | 0.72 | 0.88 | 0.49*** | 0.45*** | 0.61*** | 0.85*** | ||||||
| 5. Pain behavior | 0.71 | 0.92 | 0.16*** | 0.23*** | 0.13*** | 0.16*** | 0.85*** | |||||
| 6. Self-report pain | 0.69 | 0.90 | 0.20*** | 0.20*** | 0.21*** | 0.17*** | 0.56*** | 0.83*** | ||||
| 7. Pain catastrophizing | 0.69 | 0.87 | 0.24*** | 0.36*** | 0.37*** | 0.43*** | 0.53*** | 0.62*** | 0.83*** | |||
| 8. Female gender | 1.00 | 1.00 | 0.05*** | 0.26*** | 0.18*** | 0.15*** | 0.08*** | 0.33*** | 0.35*** | 1.00 | ||
| 9. Experienced patient | 1.00 | 1.00 | –0.15**** | –0.15*** | –0.25*** | –0.24*** | –0.11*** | –0.16*** | –0.24*** | –0.16*** | 1.00 | |
| 10. Age | 1.00 | 1.00 | –0.07**** | 0.06*** | –0.14*** | –0.11*** | –0.14*** | –0.27*** | –0.34*** | 0.00*** | 0.41*** | 1.00 |
FIGURE 2The estimated structural model.
Tests of moderation effects.
| Effect | Beta | LLCI | ULCI | p | Effect | Beta | LLCI | ULCI | p | Effect | Beta | LLCI | ULCI | p | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AS × EXP – > PBR | –0.18 | –0.42 | 0.07 | 1.15 | WO × EXP – > PBR | 0.02 | –0.19 | 0.27 | 0.14 | HD × EXP – > PBR | –0.03 | –0.30 | 0.23 | 0.21 | |||
| AS × EXP – > PCS | –0.29 | –0.48 | –0.10 | 2.43 | ∗∗ | WO × EXP – > PCS | –0.04 | –0.04 | 0.12 | 0.22 | HD × EXP – > PCS | –0.26 | –0.45 | –0.07 | 2.25 | ∗ | |
| AS × EXP – > PSR | –0.03 | –0.28 | 0.17 | 0.22 | WO × EXP – > PSR | 0.16 | –0.02 | 0.38 | 1.29 | HD × EXP – > PSR | 0.00 | –0.24 | 0.22 | 0.01 | |||
| AS × FEM – > PBR | –0.07 | –0.36 | 0.19 | 0.40 | WO × FEM – > PBR | 0.03 | –0.22 | 0.27 | 0.20 | HD × FEM – > PBR | 0.08 | –0.23 | 0.36 | 0.44 | |||
| AS × FEM – > PCS | 0.22 | 0.05 | 0.41 | 1.98 | ∗ | WO × FEM – > PCS | 0.07 | –0.13 | 0.23 | 0.67 | HD × FEM – > PCS | 0.22 | 0.05 | 0.41 | 1.98 | ∗ | |
| AS × FEM – > PSR | 0.10 | –0.15 | 0.33 | 0.70 | WO × FEM – > PSR | 0.03 | –0.20 | 0.27 | 0.23 | HD × FEM – > PSR | 0.14 | –0.06 | 0.38 | 0.99 | |||
| AS × AGE – > PBR | –0.03 | –0.23 | 0.21 | 0.20 | WO × AGE – > PBR | –0.08 | –0.30 | 0.19 | 0.54 | HD × AGE – > PBR | 0.00 | –0.24 | 0.28 | 0.00 | |||
| AS × AGE – > PCS | –0.41 | –0.62 | –0.26 | 3.76 | ∗∗∗ | WO × AGE – > PCS | –0.37 | –0.57 | –0.15 | 2.77 | ∗∗ | HD × AGE – > PCS | –0.29 | –0.45 | –0.07 | 2.31 | ∗ |
| AS × AGE– > PSR | –0.11 | –0.30 | 0.08 | 0.91 | WO × AGE – > PSR | –0.04 | –0.25 | 0.17 | 0.29 | HD × AGE – > PSR | –0.18 | –0.39 | 0.04 | 1.26 |
FIGURE 3Simple slope analysis.